News
In addition to the presentations, Viral Kansara, PhD, Vice President, Preclinical Development moderated an ARVO session entitled “Retina/RPE: New drugs, mechanisms of action, and toxicity” and Dr.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback